Gonococcal pneumonia
ICD-10 A54.84 is a billable code used to indicate a diagnosis of gonococcal pneumonia.
Gonococcal pneumonia is a rare but serious complication of gonorrhea, primarily affecting infants born to mothers with untreated gonococcal infections. The condition arises when Neisseria gonorrhoeae, the bacterium responsible for gonorrhea, spreads to the lungs, leading to pneumonia. Symptoms may include cough, fever, difficulty breathing, and chest pain. Diagnosis is typically confirmed through culture or PCR testing of respiratory secretions. Gonococcal pneumonia is more common in neonates, particularly those who have been exposed to the bacteria during delivery. Treatment involves the use of appropriate antibiotics, such as ceftriaxone or azithromycin, to effectively eradicate the infection. Prompt recognition and treatment are crucial to prevent severe complications, including respiratory failure. In adults, gonococcal pneumonia is extremely rare and usually occurs in the context of disseminated gonococcal infection. Public health measures, including contact tracing and screening of sexual partners, are essential to control the spread of gonorrhea and prevent cases of gonococcal pneumonia.
Detailed history of sexual exposure, laboratory confirmation of gonococcal infection, and treatment plans.
Diagnosis and management of gonococcal infections, including pneumonia in neonates.
Ensure all relevant tests and treatments are documented to support the diagnosis.
Complete birth history, maternal health records, and any signs of respiratory distress in the infant.
Management of newborns presenting with respiratory symptoms and maternal gonorrhea.
Documentation must clearly link the infant's symptoms to maternal infection.
Used to confirm the diagnosis of gonococcal pneumonia.
Document the site of culture and results.
Infectious disease specialists should ensure cultures are properly labeled and processed.
Common symptoms include cough, fever, difficulty breathing, and chest pain, particularly in infants.
Diagnosis is typically made through culture or PCR testing of respiratory secretions.
Treatment usually involves antibiotics such as ceftriaxone or azithromycin.
